trial summary · NCT06770023
Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension
A Pilot Study of Transseptal ECMO With the Protek Solo Cannula in Lung Transplant Candidates With Right Heart Failure From Pulmonary Hypertension
Trial record from the TrialBase DB dataset, status RECRUITING, condition Lung Transplant, sponsored by Mayo Clinic. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
The purpose of this study is to determine if transseptal extra-corporeal membrane oxygenation (ECMO) can bridge pulmonary hypertension- right heart failure (PH-RVF) patients to lung transplant safely.
Source record: https://clinicaltrials.gov/study/NCT06770023
Facts
| registry id | NCT06770023 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | PHASE1 |
| study type | INTERVENTIONAL |
| lead condition | Lung Transplant |
| sponsor | Mayo Clinic |
| sponsor class | OTHER |
| enrollment | 4 |
| start date | 2026-12-11 |
| primary completion | 2027-12 |
| completion | 2028-12 |
| results posted | not reported |
Conditions
- Lung Transplant
- Pulmonary Hypertension
Interventions
- Protek Solo Transseptal Cannula
Countries
- United States
Intervention types: DEVICE
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.